Skip to content

Medical emergency? What to do

Amnioinfusion doesn't prevent meconium aspiration

3-RXPublished September 1, 20053 min read

Key points

  • Infusion of fluid into the amniotic cavity (amnioinfusion) during labor in women with thick meconium staining of the amniotic fluid does not reduce the risk of meconium aspiration syndrome or death of the fetus or infant, new research shows.
  • The process of amnioinfusion involves infusing a neutral water-based solution into the amniotic cavity and was first introduced to treat low amniotic fluid (oligohydramnios) in the early 1980s, lead author Dr.
  • "Our study is the first large, adequately powered, multicenter trial to investigate this topic, and we found no evidence that amnioinfusion was useful for this (condition)," Fraser said.
  • The rate of death or moderate-to-severe meconium aspiration syndrome in amnioinfusion group was 4.5 percent, not significantly different than the 3.5 percent rate seen in the standard-care group.

Infusion of fluid into the amniotic cavity (amnioinfusion) during labor in women with thick meconium staining of the amniotic fluid does not reduce the risk of meconium aspiration syndrome or death of the fetus or infant, new research shows. This finding held true whether or not slowing of the fetal heart rate was detected.

Meconium aspiration syndrome occurs in when the meconium, the first feces of the newborn, is inhaled either in the uterus or just after delivery. The possibility of inhaling meconium occurs in about 5 to10 percent of births. It typically occurs when the fetus is stressed during labor and is a leading cause of serious illness or death in the newborn.

The process of amnioinfusion involves infusing a neutral water-based solution into the amniotic cavity and was first introduced to treat low amniotic fluid (oligohydramnios) in the early 1980s, lead author Dr. William D. Fraser told, (University of Montreal). Over time, however, the procedure also became used to prevent meconium aspiration syndrome.

"A number of small, single-center studies have been conducted and most of them did not show a benefit for amnioinfusion in preventing meconium aspiration syndrome," Fraser noted. "However, when the studies were grouped together...there was evidence of a reduction in risk."

"Our study is the first large, adequately powered, multicenter trial to investigate this topic, and we found no evidence that amnioinfusion was useful for this (condition)," Fraser said.

The study, which is reported in The New England Journal of Medicine, involved almost 2,000 pregnant women who had thick meconium staining of the amniotic fluid. The women were randomly assigned to receive amnioinfusion or standard care. All of the women were in labor and had been pregnant at least 36 weeks.

The rate of death or moderate-to-severe meconium aspiration syndrome in amnioinfusion group was 4.5 percent, not significantly different than the 3.5 percent rate seen in the standard-care group. The rates of c-section in the amnioinfusion and standard-care groups were also similar, at 31.8 percent and 29.0 percent, respectively.

As noted, no benefit for amnioinfusion was seen when the women were classed according to the presence or absence of irregular fetal heart rate.

While not effective, amnioinfusion did not appear to be harmful either, Fraser noted. No adverse effects were specifically linked to the procedure.

Fraser said he believes the current findings largely settle the issue of whether amnioinfusion is useful in preventing meconium aspiration syndrome. However, he said there is still a question of whether it might be useful in resource-poor areas that lack fetal heart monitoring. "Also, there is a need for studies that address the effect of amnioinfusion on clinically significant fetal heart rate abnormalities," he added.

SOURCE: The New England Journal of Medicine, September 1, 2005.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underPregnancy

Keep reading

Genetics

Genes in mother, baby raise risk of preterm birth

Genes in the mother and the fetus play a role in the risk of preterm labor, a leading cause of infant death and disability, U.S. government researchers said on Thursday. They said gene variants in the mother and…

3 min read

Pregnancy

Postpartum Baby Blues Impact Majority of New Moms

Tracy Perkins Rodriguez, 36, thought her life was finally on the upswing. When her husband returned from his third tour of duty in Iraq and Afghanistan, the couple purchased their dream home and promptly became…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.